levothyroxine sodium 0.2 MG Injection

RxCUI
1115269
RxNorm name
levothyroxine sodium 0.2 MG Injection
Display name
Levothyroxine (Injectable)
Full name
levothyroxine sodium 0.2 MG Injection
Term type
SCD
Status
Active
Strength
0.2 mg
Dose form
Injection
Route
Injectable
Updated
2026-11-04 11:50:57

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
082011
Active start
082011
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
levothyroxine sodium0.2 MG / 1 EACHlevothyroxinelevothyroxine sodium

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Injection1649574

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
levothyroxine10582

Source Vocabulary Codes#

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
25021-469-1025021-469Levothyroxine Sodium Levothyroxine Sodium AnhydrousSagent PharmaceuticalsANDA208749
42023-202-0142023-202Levothyroxine Sodium LEVOTHYROXINE SODIUM ANHYDROUSENDO USA, Inc.NDA202231
63323-647-1063323-647Levothyroxine Sodium LEVOTHYROXINE SODIUM ANHYDROUSFresenius Kabi USA, LLCNDA202231
70511-112-1070511-112Levothyroxine Sodium LEVOTHYROXINE SODIUM ANHYDROUSMAIA Pharmaceuticals, Inc.ANDA208749
70710-1834-170710-1834LEVOTHYROXINE SODIUM levothyroxine sodiumZydus Pharmaceuticals USA Inc.ANDA217066
83270-007-0183270-007Levothyroxine Sodium LEVOTHYROXINE SODIUM ANHYDROUSONESOURCE SPECIALTY PHARMA LIMITEDANDA216729

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA20874925021-469Levothyroxine Sodium Levothyroxine Sodium AnhydrousANDASagent Pharmaceuticals
NDA20223142023-202Levothyroxine Sodium LEVOTHYROXINE SODIUM ANHYDROUSNDAENDO USA, Inc.
ANDA21706670710-1834LEVOTHYROXINE SODIUM levothyroxine sodiumANDAZydus Pharmaceuticals USA Inc.
ANDA21672983270-007Levothyroxine Sodium LEVOTHYROXINE SODIUM ANHYDROUSANDAONESOURCE SPECIALTY PHARMA LIMITED

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 12 matching rows.

NDC11, Source, Active table
NDC11SourceActive
25021046910rxnav_ndcsyes
42023020201rxnav_ndcsyes
63323064710rxnav_ndcsyes
63323064721rxnav_ndcsyes
70511011210rxnav_ndcsyes
70710183401rxnav_ndcsyes
70860045210rxnav_ndcsyes
83270000701rxnav_ndcsyes
42023016101rxnav_historical
63323024710rxnav_historical
63323064711rxnav_historical
66794064702rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSONESOURCE SPECIALTY PHARMA LIMITEDae9954a5-e196-449c-abea-ebe4afbee5172026-08-12Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 83270-007-01
ndc (product): 83270-007
ndc11 (package): 83270000701
rxcui: 1115269
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSMAIA Pharmaceuticals, Inc.4e9adc35-3aba-4a0d-9c4e-7e7ee2ffdabd2026-08-05Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 70511-112-10
ndc (product): 70511-112
ndc11 (package): 70511011210
rxcui: 1115269
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMZydus Pharmaceuticals USA Inc.bf8a952c-f05b-4814-b55a-ed04be0152692025-09-16Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 70710-1834-1
ndc (product): 70710-1834
ndc11 (package): 70710183401
rxcui: 1115269
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSENDO USA, Inc.9d815416-11c9-470e-a82f-89b0bf232e122025-04-28Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 42023-202-01
ndc (product): 42023-202
ndc11 (package): 42023020201
rxcui: 1115269
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSFresenius Kabi USA, LLCce990712-49c1-4f66-9ee4-c770e8ec394c2025-04-17Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 63323-647-10
ndc (product): 63323-647
ndc11 (package): 63323064710
rxcui: 1115269
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSSagent Pharmaceuticalsf57e9b19-6f17-4520-80fc-511322cc56c92023-10-19Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 25021-469-10
ndc (product): 25021-469
ndc11 (package): 25021046910
rxcui: 1115269

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 6 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ce990712-49c1-4f66-9ee4-c770e8ec394clevothyroxine sodium 200 MCG Injection [PSN] · levothyroxine sodium 0.2 MG Injection [SCD] · levothyroxine sodium 200 MCG Injection [SY]37These highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for injection, for intravenous use Initial U.S. Approval: 196920250417
9d815416-11c9-470e-a82f-89b0bf232e12levothyroxine sodium 200 MCG Injection [PSN] · levothyroxine sodium 0.2 MG Injection [SCD] · levothyroxine sodium 200 MCG Injection [SY]35These highlights do not include all the information needed to use Levothyroxine Sodium for Injection safely and effectively. See full prescribing information for Levothyroxine Sodium for Injection. Levothyroxine Sodium for Injection Initial U.S. Approval: 196920250428
bf8a952c-f05b-4814-b55a-ed04be015269levothyroxine sodium 200 MCG Injection [PSN] · levothyroxine sodium 0.2 MG Injection [SCD] · levothyroxine sodium 200 MCG Injection [SY]34These highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for Injection, for intravenous use Initial U.S. Approval: 196920250916
4e9adc35-3aba-4a0d-9c4e-7e7ee2ffdabdlevothyroxine sodium 200 MCG Injection [PSN] · levothyroxine sodium 0.2 MG Injection [SCD] · levothyroxine sodium 200 MCG Injection [SY]34These highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for injection, for intravenous use Initial U.S. Approval: 196920190130
ae9954a5-e196-449c-abea-ebe4afbee517levothyroxine sodium 200 MCG Injection [PSN] · levothyroxine sodium 0.2 MG Injection [SCD] · levothyroxine sodium 200 MCG Injection [SY]32These highlights do not include all the information needed to use Levothyroxine Sodium for Injection safely and effectively. See full prescribing information for Levothyroxine Sodium for Injection. Levothyroxine Sodium for Injection Initial U.S. Approval: 196920250526
f57e9b19-6f17-4520-80fc-511322cc56c9levothyroxine sodium 200 MCG Injection [PSN] · levothyroxine sodium 0.2 MG Injection [SCD] · levothyroxine sodium 200 MCG Injection [SY]31These highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for injection, for intravenous use Initial U.S. Approval: 196920231019

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
ce990712-49c1-4f66-9ee4-c770e8ec394cThese highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for injection, for intravenous use Initial U.S. Approval: 1969Fresenius Kabi USA, LLC20261102
ae9954a5-e196-449c-abea-ebe4afbee517These highlights do not include all the information needed to use Levothyroxine Sodium for Injection safely and effectively. See full prescribing information for Levothyroxine Sodium for Injection. Levothyroxine Sodium for Injection Initial U.S. Approval: 1969ONESOURCE SPECIALTY PHARMA LIMITED | Onesource Specialty Pte. Limited20260812
4e9adc35-3aba-4a0d-9c4e-7e7ee2ffdabdThese highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for injection, for intravenous use Initial U.S. Approval: 1969MAIA Pharmaceuticals, Inc. | Gland Pharma Limited20260805
ae9954a5-e196-449c-abea-ebe4afbee517These highlights do not include all the information needed to use Levothyroxine Sodium for Injection safely and effectively. See full prescribing information for Levothyroxine Sodium for Injection. Levothyroxine Sodium for Injection Initial U.S. Approval: 1969ONESOURCE SPECIALTY PHARMA LIMITED | Onesource Specialty Pte. Limited20260327
bf8a952c-f05b-4814-b55a-ed04be015269These highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for Injection, for intravenous use Initial U.S. Approval: 1969Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited20250916
ae9954a5-e196-449c-abea-ebe4afbee517These highlights do not include all the information needed to use Levothyroxine Sodium for Injection safely and effectively. See full prescribing information for Levothyroxine Sodium for Injection. Levothyroxine Sodium for Injection Initial U.S. Approval: 1969ONESOURCE SPECIALTY PHARMA LIMITED | Onesource Specialty Pte. Limited20250526
9d815416-11c9-470e-a82f-89b0bf232e12These highlights do not include all the information needed to use Levothyroxine Sodium for Injection safely and effectively. See full prescribing information for Levothyroxine Sodium for Injection. Levothyroxine Sodium for Injection Initial U.S. Approval: 1969ENDO USA, Inc. | Fresenius Kabi USA, LLC20250428
ce990712-49c1-4f66-9ee4-c770e8ec394cThese highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for injection, for intravenous use Initial U.S. Approval: 1969Fresenius Kabi USA, LLC20250417
9f652cbf-a3f5-4b7e-a5fd-a902c6ead389These highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for injection, for intravenous use Initial U.S. Approval: 1969Athenex Pharmaceutical Division, LLC.20240304
f57e9b19-6f17-4520-80fc-511322cc56c9These highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for injection, for intravenous use Initial U.S. Approval: 1969Sagent Pharmaceuticals20231019
6e77ac5a-6404-2556-e053-2991aa0a92e6Levothyroxine Sodium for Injection These highlights do not include all the information needed to use Levothyroxine Sodium for Injection safely and effectively. See full prescribing information for Levothyroxine Sodium for Injection. LEVOTHYROXINE sodium for injection, for intravenous use Initial U.S. Approval: 1969Piramal Critical Care, Inc. | Fresenius Kabi, LLC20191224
4e9adc35-3aba-4a0d-9c4e-7e7ee2ffdabdThese highlights do not include all the information needed to use LEVOTHYROXINE SODIUM FOR INJECTION safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM FOR INJECTION. LEVOTHYROXINE SODIUM for injection, for intravenous use Initial U.S. Approval: 1969MAIA Pharmaceuticals, Inc. | Gland Pharma Limited20190130
7820d23f-17e8-448c-8a40-c3278831fe8eThese highlights do not include all the information needed to use Levothyroxine Sodium for Injection safely and effectively. See full prescribing information for Levothyroxine Sodium for Injection. Levothyroxine Sodium for Injection Initial U.S. Approval: 1969Par Pharmaceutical Companies, Inc.20151211

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCH03AAThyroid hormonesATC1-4levothyroxine sodium
FDASPLD013974ThyroxineCHEMhas_chemical_structurelevothyroxine
FDASPLN0000175945l-ThyroxineEPChas_epclevothyroxine
MEDRTD013974ThyroxineCHEMhas_ingredientlevothyroxine sodium
MEDRTD013974ThyroxineCHEMhas_ingredientlevothyroxine
MEDRTD000309Adrenal InsufficiencyDISEASEci_withlevothyroxine
MEDRTD000309Adrenal InsufficiencyDISEASEci_withlevothyroxine sodium
MEDRTD004342Drug HypersensitivityDISEASEci_withlevothyroxine
MEDRTD004342Drug HypersensitivityDISEASEci_withlevothyroxine sodium
MEDRTD006042GoiterDISEASEmay_treatlevothyroxine
MEDRTD006042GoiterDISEASEmay_treatlevothyroxine sodium
MEDRTD007037HypothyroidismDISEASEmay_preventlevothyroxine
MEDRTD007037HypothyroidismDISEASEmay_preventlevothyroxine sodium
MEDRTD009203Myocardial InfarctionDISEASEci_withlevothyroxine sodium
MEDRTD009203Myocardial InfarctionDISEASEci_withlevothyroxine
MEDRTD009230MyxedemaDISEASEmay_treatlevothyroxine sodium
MEDRTD009230MyxedemaDISEASEmay_treatlevothyroxine
MEDRTD013959Thyroid DiseasesDISEASEmay_diagnoselevothyroxine
MEDRTD013959Thyroid DiseasesDISEASEmay_diagnoselevothyroxine sodium
MEDRTD013964Thyroid NeoplasmsDISEASEmay_treatlevothyroxine
MEDRTD013964Thyroid NeoplasmsDISEASEmay_treatlevothyroxine sodium
MEDRTD013967Thyroiditis, AutoimmuneDISEASEmay_treatlevothyroxine sodium
MEDRTD013967Thyroiditis, AutoimmuneDISEASEmay_treatlevothyroxine
MEDRTD013971ThyrotoxicosisDISEASEmay_treatlevothyroxine
MEDRTD013971ThyrotoxicosisDISEASEci_withlevothyroxine sodium
MEDRTD013971ThyrotoxicosisDISEASEmay_treatlevothyroxine sodium
MEDRTD013971ThyrotoxicosisDISEASEci_withlevothyroxine
MEDRTN0000000237Thyroid Hormone Receptor AgonistsMOAhas_moalevothyroxine
MEDRTN0000000237Thyroid Hormone Receptor AgonistsMOAhas_moalevothyroxine sodium
MEDRTN0000008347Cellular Synthetic Activity AlterationPEhas_pelevothyroxine
MEDRTN0000008347Cellular Synthetic Activity AlterationPEhas_pelevothyroxine sodium
MEDRTN0000009340Increased GluconeogenesisPEhas_pelevothyroxine
MEDRTN0000009340Increased GluconeogenesisPEhas_pelevothyroxine sodium
MEDRTN0000009399Increased Metabolic RatePEhas_pelevothyroxine
MEDRTN0000009399Increased Metabolic RatePEhas_pelevothyroxine sodium

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.2 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA208749
CODESANDAANDA216729
CODESANDAANDA217066
CODESNDANDA202231
CODESVUID4002325
NAMESPrescribable Synonymlevothyroxine sodium 200 MCG Injection
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceVeterans Health Administration National Drug File